HC Wainwright & Co. Reiterates Aldeyra Therapeutics (ALDX) Buy Recommendation

Fintel reports that on June 30, 2023, HC Wainwright & Co. reiterated coverage of Aldeyra Therapeutics (NASDAQ:ALDX) with a Buy recommendation.

admin